variants
News
2023.09.05
This article is the third in a series devoted to the hopes of HIV-AIDS research, on the occasion of the 40th anniversary of the identification of the virus...
News
2023.06.06
This article is the first in a series devoted to the hopes of HIV-AIDS research, on the occasion of the 40th anniversary of the identification of the virus...
Report
2024.03.12
Vaccination does not offer sufficient protection against severe forms of COVID-19 for people with a weakened immune system. For these individuals, monoclonal...
News
2023.06.16
In 2022, the Institut Pasteur’s international focus was on initiating and strengthening partnerships and scientific collaborations, especially with...
News
2023.01.27
"Louis Pasteur would probably be proud to see us gathered today to celebrate scientific research, two hundred years (and thirty days!) after his birth, on...
Document de presse
2022.12.13
Epidemics, pandemics: a never-ending story? – a look back at the conference held on December 7, 2022
In connection with the bicentenary of Louis Pasteur’s birth, a conference entitled "Epidemics, pandemics: a never-ending story?" was held on Wednesday December...
Document de presse
2022.10.20
Although the mechanisms by which SARS-CoV-2 enters host cells are increasingly well documented, the direct molecular interactions between virus and host remain...
Document de presse
2022.10.21
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by...
News
2022.09.05
We are looking for volunteers to take part in the CORSER-5 study. The study was launched in March 2022 to compare the immunity of COVID-19-positive individuals...
News
2022.08.25
Scientists at the Institut Pasteur demonstrated in 2003 that there is a genetic component in autism. The same team has now studied the impact of various...